MARKET

AROG

AROG

Arog Pharmaceuticals
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.0000
0.00%
Closed 09:30 09/18 EDT
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AROG and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Industry

Biotechnology & Medical Research
-0.65%
Pharmaceuticals & Medical Research
-0.05%

Hot Stocks

Name
Price
%Change

About AROG

Arog Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing crenolanib, which is a mutation-resistant type I pan-FLT3 inhibitor for cancer patients. The Company has commenced two pivotal Phase III clinical trials of crenolanib in FLT3-mutated acute myeloid leukemia (AML). The Company has also initiated Phase III clinical trial of CRENOGIST in patients with advanced or metastatic gastrointestinal stromal tumors (GIST) with a specific mutation (DD842V) in the platelet-derived growth factor receptor A (PDGFRA) gene.
More

Webull offers Arog Pharmaceuticals Inc (AROG) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.